IBA (Ion Beam Applications S.A.) has completed the first two installations of the ProteusONE* solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.
As described in a company press release, "These achievements display IBA’s superiority in installing proton therapy systems quickly and efficiently. IBA provides the quickest installation time on the market, with a majority of its projects completed under a period of 12 months. These projects demonstrate IBA’s speed of delivery, from securing the contract to the installation of the equipment, enabling the customer to treat patients faster.
"The single room ProteusONE solution, installed and maintained by IBA, is the industry’s only truly compact Intensity Modulated Proton Therapy (IMPT) system. It provides a unique open gantry environment, designed to facilitate the treatment workflow for radiation therapists and optimize the patient experience by providing a comfortable and soothing environment. Its compact design makes it easy to install, integrate, operate and finance."
Hokkaido Ohno Memorial Hospital expects to start treating its first patient in the coming weeks whilst Narita Memorial Proton Center plans to start treatment in September 2018.
Marc Van Der Burght, Executive Vice-President, Proton Therapy Installation at IBA, commented: “We are proud to confirm the reliable installation time of our Proteus®ONE proton therapy system. Our experience with installations that are less than 12 months surpasses by far competitors in the industry. IBA is leading the proton therapy industry by combining cutting-edge proton therapy technology with market leading delivery for the benefit of our customers and their patients.”
Makoto Narita MD, Chairman, Narita Memorial Hospital in Toyohashi added: “We were able to open the Proton Therapy Center in a very small space downtown thanks to the compact design of the Proteus®ONE manufactured by IBA. This convenient location means that outpatient treatment emphasizing social life becomes possible. We will continue working together with IBA to provide the most advanced and patient-friendly proton therapy treatment available.”
Kazushi Kishi MD, PHD, Director of SAFRA, and a Vice-President of Hokkaido Ohno Memorial Hospital in Sapporo, stated: “We are pleased to announce that the first IBA compact proton machine in Asia has been safely and successfully installed in our facility. We are now fully dedicated to preparing for our first patient to be treated with this state-of-the-art compact and high-performance proton therapy unit from IBA.”
IBA installs two ProteusONE proton therapy solutions in Japan in less than a year. Appl Rad Oncol.